Cushman & Wakefield Divests of Russian Operations

The firm to exit from all service delivery within Russia

CHICAGO--(BUSINESS WIRE)-- Cushman & Wakefield (NYSE: CWK) today announced that the firm has reached a definitive agreement to transfer its business in Russia to a local operator.

This transition of the business will allow the new owners to support Russian employees, while maintaining continuity of essential services to clients.

This transaction is not material to the firm’s financial statements or future operations.

Cushman & Wakefield would like to publicly thank its colleagues for their hard work and dedication to the firm’s clients, while recognizing the current extraordinary circumstances and uncertainty those colleagues are experiencing.

Cushman & Wakefield also continues to support its Ukrainian colleagues by mobilizing resources, including its Global Employee Assistance Fund. In addition, the firm is also supporting its many employees in neighbouring countries who are responding to the humanitarian crisis through a variety of means.

Cushman & Wakefield stands firmly with the global community in the hope for peace.

About Cushman & Wakefield

Cushman & Wakefield (NYSE: CWK) is a leading global real estate services firm that delivers exceptional value for real estate occupiers and owners. Cushman & Wakefield is among the largest real estate services firms with approximately 50,000 employees in over 400 offices and approximately 60 countries. In 2021, the firm had revenue of $9.4 billion across core services of property, facilities and project management, leasing, capital markets, and valuation and other services. To learn more, visit www.cushmanwakefield.com or follow @CushWake on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220325005465/en/

Brad Kreiger
Corporate Communications
[email protected]

Source: Cushman & Wakefield

You May Also Be Interested In

• Booz Allen Hamilton to Host Conference Call to Discuss First Quarter Fiscal 2027 Results on Friday, July 24, 2026
• AngloGold Ashanti Announces Date for General Meeting of Shareholders in Relation to Proposed Share Repurchase Programme
• BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026